Businesspublished

Enflame Opens $910M Shanghai IPO Subscription, Testing Its Specialized AI-Chip Bet

The offering would fund Enflame’s next two chip generations and related software projects, while investors weigh a focused architecture against domestic competition and heavy reliance on Tencent revenue.

By 2 min read
Enflame Opens $910M Shanghai IPO Subscription, Testing Its Specialized AI-Chip Bet
Enflame Opens $910M Shanghai IPO Subscription, Testing Its Specialized AI-Chip Bet

Listen to this story

The audio brief

About 1:30
0:001:30
Read transcript
Enflame Technology is opening subscriptions for a 6.12-billion-yuan, or 910.3-million-dollar, initial public offering on Shanghai’s Star Market. The company will issue 43.04 million new shares at 142.18 yuan each, equal to 10 percent of its enlarged share capital. The money is earmarked for Enflame’s fifth- and sixth-generation AI chips, along with software-and-hardware projects designed to help commercialize them. The central bet is on DSA, or domain-specific architecture. Instead of building a general-purpose GPU for a broad range of workloads, Enflame is optimizing for selected tasks, including AI inference. That narrower design may improve computing efficiency, but it also gives the company less flexibility than the approach used by Nvidia and several Chinese rivals. The IPO arrives as Moore Threads, MetaX Integrated Circuits, and Biren Technology have also pursued major public fundraisings, intensifying China’s domestic AI-chip race. Beijing’s push for technological self-reliance is supporting the sector, but Enflame still faces competition from Huawei and other local chipmakers. There is also a company-specific risk: Tencent is a major backer, and Enflame relies substantially on Tencent for revenue. So the market test goes beyond the offer price. Investors will be watching whether a focused chip architecture can win enough targeted workloads—and whether Enflame can broaden its customer base while financing its next two generations.

Story brief

3 key points

Enflame’s Star Market offering gives China’s specialized AI-chip strategy a public-market test: 43.04 million new shares at 142.18 yuan, with proceeds earmarked for fifth- and sixth-generation chips and integrated software-hardware development. Its domain-specific architecture targets efficiency on selected workloads such as inference, unlike broad-purpose GPUs. The larger risk is commercial concentration: Tencent...

  1. 01

    Strategic, institutional, and retail allocations total 8.61 million, 27.54 million, and 6.89 million shares, respectively.

  2. 02

    The deal follows IPOs by Moore Threads, MetaX Integrated Circuits, and Biren Technology, intensifying China’s domestic AI-chip race.

  3. 03

    Enflame’s DSA bet trades general-purpose flexibility for potentially higher efficiency on targeted workloads such as inference.

Enflame Technology is opening subscriptions for a 6.12 billion yuan, or US$910.3 million, initial public offering on Shanghai’s Star Market. The financing puts public investors behind a chipmaker pursuing architecture optimized for targeted AI workloads, rather than the broad-purpose GPU approach used by several prominent rivals.

Enflame said it would issue 43.04 million shares at 142.18 yuan each. Those new shares equal 10% of its enlarged share capital, which will be about 430 million shares. An earlier account of the regulatory filing described the planned deal as a rounded 6 billion yuan, or US$892.21 million, offering with subscriptions opening September 2.

A narrower path than a general-purpose GPU

Enflame’s differentiator is domain-specific architecture, or DSA. The company’s approach is designed to maximize computing efficiency for selected tasks, including AI inference. That makes its product strategy more focused than general-purpose graphics processing units, which are intended to handle a wider range of workflows.

What the new money is meant to build

Enflame plans to direct the IPO proceeds toward developing and commercializing its fifth- and sixth-generation AI chips. It also plans advanced AI software-and-hardware collaborative innovation projects, making the offering a funding vehicle for products and the surrounding system work needed to bring them to market.

How the shares are allocated

  • 8.61 million shares are allocated to strategic investors.
  • 27.54 million shares are allocated to institutional investors.
  • 6.89 million shares are allocated to retail investors.

The market test extends beyond the offer price

The listing arrives during a run of major public fundraisings by Chinese AI-chip companies, including Moore Threads, MetaX Integrated Circuits and Biren Technology. The sector is benefiting from Beijing’s push for technological self-reliance and domestic AI-infrastructure construction, but Enflame competes with Huawei and other local AI-chip makers for a place in that buildout.

There is a more company-specific constraint. Tencent is a major Enflame backer, and Enflame has substantial revenue dependence on Tencent. The public-market question is therefore not only whether targeted chips can win workloads, but whether Enflame can turn that design choice into a broader customer base while facing fierce domestic competition.

Sources

  1. scmp.comEnflame’s US$900m IPO tests appetite for China’s ‘little dragon’ AI chipmakers
  2. wmbdradio.comAI chipmaker Enflame sets subscription date for near $900 million Shanghai IPO